Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies

OBJECTIVES: Due to the heterogeneity of PCa, the clinical indicators used for PCa can't satisfy risk prognostication and personalized treatment. It is imperative to develop novel biomarkers for prognosis prediction and therapy response in PCa. Accumulating evidence shows that non-mutational epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Xiao, Cai, Zhouda, Chen, Guo, Cai, Chao, Chen, Jiahong, Liang, Yingke, Zhuo, Yangjia, Liu, Jianming, Huang, Liangliang, Ouyang, Bin, Wei, Yanni, Jia, Zhenyu, Deng, Junhong, Zhong, Weide, Lu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167087/
https://www.ncbi.nlm.nih.gov/pubmed/37155024
http://dx.doi.org/10.1007/s12672-023-00671-w

Ejemplares similares

Ejemplares similares